Nebivolol | compare suppliers & send inquiries for free
Looking for Nebivolol 118457-14-0?
- API | Excipient name:
- Nebivolol
- Synonyms:
- Narbivolol, Nebivololum
- Cas Number:
- 118457-14-0
- DrugBank number:
- DB04861
- Unique Ingredient Identifier:
- 030Y90569U
About Nebivolol
Some technical information about this product: Nebivolol is a racemic mixture of 2 enantiomers where one is a beta adrenergic antagonist and the other acts as a cardiac stimulant without beta adrenergic activity. Treatment with nebivolol leads to a greater decrease in systolic and diastolic blood pressure than atenolol, propranolol, or pindolol. Nebivolol and other beta blockers are generally not first line therapies as many patients are first treated with thiazide diuretics.[A182594] Nebivolol was granted FDA approval on 17 December 2007.
Not sure if this is the exact product you're looking for? Contact the supplier by using the send inquiry button.
Nebivolol manufacturers | traders | suppliers
We have 16 companies offering Nebivolol from 5 different countries.
Get in contact with the supplier of your choice:
- Apister life science pvt ltd from India
- Amuna Pharmaceuticals from India
- TIEFENBACHER API + Ingredients from Germany
- Hetero Drugs from India
- Vasudha Pharma from India
- Maithili Life Sciences from India
- Zhejiang Ausun from China
- Honour Lab from India
- Cadila Pharma from India
- Corden Pharma from Germany
- Fabbrica Italiana Sintetici (FIS) from Italy
- Macleods Pharma from India
- Zhejiang Huahai Pharma from China
- Torrent Pharma from India
- MSN Pharma from India
- GVK Biosciences Pvt Ltd from India
Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.
You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.